7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60057 | Notum pectinacetylesterase-1 | Others | |
Notum pectinacetylesterase-1 is a Notum Pectinacetylesterase inhibitor with IC50 < 0.025 μM. | |||
T73212 | Notum-IN-1 | ||
Notum-IN-1 is an orally administered, selective, and brain-penetrating compound that acts as an inhibitor of Notum. It effectively inhibits Wnt signaling in vivo in mice. | |||
T38776 | LP-922056 | Wnt/beta-catenin | |
LP-922056 is an inhibitor of Notum Pectinacetylesterase with EC50 values of 21 nM, 55 nM for human and mouse, respectively. | |||
T77524 | Carboxylesterase-IN-2 | Wnt/beta-catenin , Lipid | |
Carboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases. | |||
T23602 | ABC99 | ABC 99,ABC-99 | Wnt/beta-catenin |
ABC99 is a selective irreversible inhibitor of the wnt-deacylating enzyme. ABC99 inhibited NOTUM (IC50: 13 nM). It also showed excellent selectivity across the serine hydrolase family. | |||
T60788 | Carboxylesterase-IN-3 | Wnt/beta-catenin , Lipid | |
Carboxylesterase-IN-3 is a potent inhibitor of Carboxylesterase Notum (IC50 ≤ 10 nM).Carboxylesterase-IN-3 has the potential to study cancer diseases. | |||
T60537 | ARUK3001185 | ||
ARUK3001185 (Compound 8l) is a potent, selective, orally active, and brain-penetrant Notum inhibitor(IC50 = 6.7 nM) that is suitable for oral dosing in rodent models of disease [1]. |